Incidence and survival differences in esophageal cancer among ethnic groups in the United States

被引:41
作者
Chen, Zheling [1 ]
Ren, Yinghong [2 ]
Du, Xianglin L. [3 ]
Yang, Jiao [1 ]
Shen, Yanwei [1 ]
Li, Shuting [1 ]
Wu, Yunying [1 ]
Lv, Meng [1 ]
Dong, Danfeng [1 ]
Li, Enxiao [1 ]
Li, Wei [4 ]
Liu, Peijun [5 ]
Yang, Jin [1 ]
Yi, Min [1 ,6 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China
[2] Shangluo Cent Hosp, Dept Internal Med, Shangluo, Shaanxi, Peoples R China
[3] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA
[4] Weapon Ind Hlth Res Inst, Xian, Shaanxi, Peoples R China
[5] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Translat Med, Xian, Shaanxi, Peoples R China
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA
关键词
esophageal cancer; the united states; survival; incidence rate; ethnicity; SQUAMOUS-CELL CARCINOMA; ADENOCARCINOMA INCIDENCE; RACIAL DISPARITIES; RISK; POPULATION; TRENDS; MORTALITY; EXPRESSION; PATTERNS; INCREASE;
D O I
10.18632/oncotarget.16694
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: This study was performed to identify the differences in incidence, clinicopathological features, and survival in esophageal cancer among ethnic groups in the United States and to determine the reasons for the differences. Result: A total of 49,766 patients were included. Black and Asian groups had a higher proportion of squamous cell carcinoma (ESCC) (85.5% and 75.4%, respectively) and mid-esophagus tumor (43.2% and 37.7% respectively) than the non-Hispanic white and Hispanic white groups. The incidences of ESCC in all ethnic groups declined since 1973, especially in black males. At the same time, incidences of esophageal adenocarcinoma (EAC) dramatically increased in white males since 1973. And incidences of ESCC and EAC were the lowest and stable in Asian female. Multivariable models showed that patients who were male, or black, or had larger tumors, or positive lymph nodes had an increased risk of death from esophageal cancer, while patients with ESCC or diagnosed after 2005 or treated with surgery had a lower likelihood of death. For ESCC, the black patients had the lowest DSS, while for EAC there were no significant differences in DSS among the ethnic/racial groups. Materials and Method: From the Surveillance, Epidemiology, and End Results Program database, patients diagnosed with esophageal cancer from 1998-2013 were identified. Differences in incidences, clinicopathological features, treatments, and disease-specific survival (DSS) in four broad racial/ethnic groups were compared. Conclusion: Histological type distribution between racial groups could be an important consideration in the incidence and the survival trend but other factors could also have an effect.
引用
收藏
页码:47037 / 47051
页数:15
相关论文
共 51 条
  • [11] CYP3A5 genotypes and risk of oesophageal cancer in two South African populations
    Dandara, C
    Ballo, R
    Parker, MI
    [J]. CANCER LETTERS, 2005, 225 (02) : 275 - 282
  • [12] p16 hypermethylation: A biomarker for increased esophageal cancer susceptibility in high incidence region of North East India
    Das, Mandakini
    Saikia, Bhaskar Jyoti
    Sharma, Santanu Kumar
    Sekhon, Gaganpreet Singh
    Mahanta, Jagadish
    Phukan, Rup Kumar
    [J]. TUMOR BIOLOGY, 2015, 36 (03) : 1627 - 1642
  • [13] Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma
    de Martel, C
    Llosa, AE
    Farr, SM
    Friedman, GD
    Vogelman, JH
    Orentreich, N
    Corley, DA
    Parsonnet, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) : 761 - 767
  • [14] Does the Incidence of Adenocarcinoma of the Esophagus and Gastric Cardia Continue to Rise in the Twenty-First Century?-a SEER Database Analysis
    Dubecz, A.
    Solymosi, N.
    Stadlhuber, R. J.
    Schweigert, M.
    Stein, H. J.
    Peters, J. H.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (01) : 124 - 129
  • [15] Should every region use the same gastric cancer scanning and treatment approaches? let's reconsider: a northeastern turkey example
    Fatih, Albayrak
    Yasin, Ozturk
    Hakan, Dursun
    Yavuz, Albayrak
    [J]. BMC GASTROENTEROLOGY, 2016, 16
  • [16] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [17] Gastrointestinal Malignancies: When Does Race Matter?
    Fitzgerald, Timothy L.
    Bradley, Cathy J.
    Dahman, Bassam
    Zervos, Emmanuel E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (05) : 645 - 652
  • [18] Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
    Ford, Hugo E. R.
    Marshall, Andrea
    Bridgewater, John A.
    Janowitz, Tobias
    Coxon, Fareeda Y.
    Wadsley, Jonathan
    Mansoor, Wasat
    Fyfe, David
    Madhusudan, Srinivasan
    Middleton, Gary W.
    Swinson, Daniel
    Falk, Stephen
    Chau, Ian
    Cunningham, David
    Kareclas, Paula
    Cook, Natalie
    Blazeby, Jane M.
    Dunn, Janet A.
    [J]. LANCET ONCOLOGY, 2014, 15 (01) : 78 - 86
  • [19] Cervical esophageal cancer: A population-based study
    Grass, G. Daniel
    Cooper, S. Lewis
    Armeson, Kent
    Garrett-Mayer, Elizabeth
    Sharma, Anand
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (06): : 808 - 814
  • [20] Worldwide incidence, mortality and time trends for cancer of the oesophagus
    Gupta, Bhawna
    Kumar, Narinder
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (02) : 107 - 118